InspireMD (NSPR) announced the appointment of Raymond W. Cohen to its Board of Directors. Until May of 2025, Mr. Cohen served as Chairman of SoniVie, a clinical stage company focused on a device treatment for hypertension until it was acquired by Boston Scientific for $600 million.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NSPR: